Adhesion Molecules in the Shwartzman Response

  • Lawrence W. Argenbright
  • Randall W. Barton
Conference paper

Abstract

The classical Shwartzman reaction was elicited in rabbits in intradermal sites that had been “prepared” 24 h previously by the injection of culture filtrate of Bacillus typhosus followed by an intravenous “challenge” injection of the same filtrate (1). It has been shown that the active agent in the filtrate that is responsible for the thrombohemorrhagic response that develops within 4 h after challenge is endotoxin (2).

Keywords

Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Allergic Contact Dermatitis Rabbit Skin Challenge Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shwartzman, G. 1928. A new phenomenon of local skin reactivity to B. typhosus culture filtrate. Proc. Soc. Exp. Biol. Med. 25:560.Google Scholar
  2. 2.
    Movat, H.Z., B.J. Jaynes, S. Wasi, K.W. Movat, and M.M. Kopaniak. 1980. Quantitation of the development and progression of the local Shwartzman reaction. In “Bacterial Endotoxins and Host Response.” M.K. Agarwal, editor. Elsevier/North-Holland, Amsterdam, pp. 179–201.Google Scholar
  3. 3.
    Movat, H.Z., C.E. Burrows, M.I. Cybulsky, and C.A. Dinarello. 1987. Acute inflammation and a Shwartzman reaction induced by interleukin-1 and tumor necrosis factor. Am. J. Pathol. 129:463.PubMedGoogle Scholar
  4. 4.
    Beck, G., G.S. Habicht, J.L. Benach, and F. Miller. 1986. Interleukin-1: a common endogenous mediator of inflammation and the local Shwartzman reaction. J. Immunol. 136:3025.PubMedGoogle Scholar
  5. 5.
    Fehr, J., C. Dahinden, and R. Russi. 1984. Formylated chemotactic peptides can mimic the secondary, provoking endotoxin injection in the generalized Shwartzman reaction. J. Infect. Dis. 150:160.PubMedCrossRefGoogle Scholar
  6. 6.
    Stetson, C.A., and R.A. Good. 1951. Shwartzman phenomenon—participation of polymorphonuclear leukocytes. J. Exp. Med. 93:49.PubMedCrossRefGoogle Scholar
  7. 7.
    Anderson, D.C., F.C. Schmalsteig, M.A. Aranout, S. Kohl, M.F. Tosi, N. Dana, G.J. Buffone, B.J. Hughes, B.R. Brinkley, W.D. Dickey, J.S. Abramson, T. Springer, L.A. Boxer, J.M. Hollers, and C.W. Smith. 1984. Abnor-malities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): a common relationship to diminished cell adherence. J. Clin. Invest. 74:536.PubMedCrossRefGoogle Scholar
  8. 8.
    Springer, T.A. 1990. Adhesion receptors of the immune system. Nature 346:425.PubMedCrossRefGoogle Scholar
  9. 9.
    Todd, R.F., M.A. Aranout, R.E. Rosin, C.A. Crowley, W.A. Peters, and B.M. Babior. 1984. Subcellular localization of the large subunit of Mol. a surface glycoprotein associated with neutrophil adhesion. J. Clin. Invest. 74:1280.PubMedCrossRefGoogle Scholar
  10. 10.
    Miller, L.J., D.F. Bainton, N. Borregaard, and T.A. Springer. 1987. Stimulated mobilization of monocyte Mac-1 and p150, 95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J. Clin. Invest. 80:535.PubMedCrossRefGoogle Scholar
  11. 11.
    Buyon, J.P., S.B. Abramson, M.R. Philips, S.G. Slade, G.D. Ross, G. Weissmann, and R.J. Winchester. 1988. Dissociation between increased surface expression of gp165,95 and homotypic neutrophil aggregation. J. Immunol. 140:3156.PubMedGoogle Scholar
  12. 12.
    Vedder, N.B., and J.M. Harlan. 1988. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J. Clin. Invest. 81:676.PubMedCrossRefGoogle Scholar
  13. 13.
    Rothlein, R., and T.A. Springer. 1986. The requirement for lymphocyte-function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester. J. Exp. Med. 163:1132.PubMedCrossRefGoogle Scholar
  14. 14.
    Pober, J.S., M.A. Gimbrone, Jr., L.A. Lapierre, D.L. Mendrick, W. Fiers, R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J. Immunol. 137:1893.PubMedGoogle Scholar
  15. 15.
    Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adhesion molecule (ICAM-1). J. Immunol. 137:245.PubMedGoogle Scholar
  16. 16.
    Smith, C.W., S.D. Marlin, R. Rothlein, C. Toman, and D.C. Anderson. 1989. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83:2008.PubMedCrossRefGoogle Scholar
  17. 17.
    Griffiths, C.E.M., and B.J. Nickoloff. 1989. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocyte infiltration in allergic contact dermatitis (Rhus dermatitis). Am. J. Pathol. 135:1045.PubMedGoogle Scholar
  18. 18.
    Adams, D.H., S.G. Hubscher, J. Shaw, R. Rothlein, and J.M. Neuberger. 1989. Intercellular adhesion molecule-1 on liver allografts during rejection. Lancet 2:1122.PubMedCrossRefGoogle Scholar
  19. 19.
    Cosimi, A.B., D. Conti, F.L. Delmonico, F.I. Preffer, S.-L., Wee R. Roth-lein, R.B. Faanes, and R.B. Colvin. 1990. Therapy with a monoclonal antibody to the adhesion molecule ICAM-1. I. Effects on allograft rejection in non-human primates. J. Immunol. 144:4604.PubMedGoogle Scholar
  20. 20.
    Barton, R.W., R. Rothlein, J. Ksiazek, and C. Kennedy. 1989. The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation. J. Immunol. 143:1278.PubMedGoogle Scholar
  21. 21.
    Wegner, CD., R.H. Gundel, P. Reilly, N. Haynes, L.E. Letts, and R. Rothlein. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456.PubMedCrossRefGoogle Scholar
  22. 22.
    Argenbright, L.A., L.G. Letts, and R. Rothlein. 1991. Monoclonal antibodies to the leukocyte membrane CD18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial cell adhesion in rabbits. J. Leak. Biol. 49:253.Google Scholar
  23. 23.
    Mori, W. 1983. Intravascular coagulation as a clinical manifestation of the Shwartzman reaction. Biblio. Haematol. 49:41.Google Scholar
  24. 24.
    Abramson. 1988. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum. 31:632.PubMedCrossRefGoogle Scholar
  25. 25.
    Fauci, A. S. 1987. The Vasculitic syndromes. In “Principles of Internal Medicine.” E. Braunwald, K. Isselbacher, R. Petersdorf, J. Wilson, J. Martin, and A. Fauci, editors. McGraw-Hill, New York. pp. 1438–1445.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1993

Authors and Affiliations

  • Lawrence W. Argenbright
  • Randall W. Barton

There are no affiliations available

Personalised recommendations